Human papillomaviruses (HPV) of the genus β are thought to play a role in human skin cancers, but this has been difficult to establish using epidemiologic approaches. To gain insight into the transforming activities of β-HPV, transgenic mouse models have been generated that develop skin tumors. Recent evidence suggests a central role of signal transducer and activator of transcription 3 (Stat3) as a transcriptional node for cancer cell-autonomous initiation of a tumor-promoting gene signature associated with cell proliferation, cell survival, and angiogenesis. Moreover, high levels of phospho-Stat3 have been detected in tumors arising in HPV8-CER transgenic mice. In this study, we investigate the in vivo role of Stat3 in HPV8-induced skin carcinogenesis by combining our established experimental model of HPV8-induced skin cancer with epidermis-restricted Stat3 ablation. Stat3 heterozygous epidermis was less prone to tumorigenesis than wild-type epidermis. Three of the 23 (13%) Stat3 +/− :HPV8 animals developed tumors within 12 weeks of life, whereas 54.3% of Stat3 +/+ : HPV8 mice already exhibited tumors in the same observation period (median age for tumor appearance, 10 weeks). The few tumors that arose in the Stat3 +/− :HPV8 mice were benign and never progressed to a more malignant phenotype. Collectively, these results offer direct evidence of a critical role for Stat3 in HPV8-driven epithelial carcinogenesis. Our findings imply that targeting Stat3 activity in keratinocytes may be a viable strategy to prevent and treat HPV-induced skin cancer. Cancer Res; 70(20); 7938-48.
Introduction
Human papillomaviruses (HPV) are small DNA tumor viruses that are strictly epitheliotropic and infect keratinocytes at a wide range of body sites. More than 120 different types of HPV have been identified to date, classified into several phylogenetic groups (1) . Of these, the α-genus HPVs, associated with infections of mucosal epithelia, are the best characterized and can be grouped into "low-risk" and "highrisk" types depending on the relative tendency of the virusinduced neoplasm to undergo malignant progression (2, 3) .
β-HPVs are associated with infections of the skin and comprise a similarly large group of HPVs (4, 5) . They cause widespread inapparent or asymptomatic infections in the general population, and children become infected at an early age. In immunosuppressed patients and individuals suffering from epidermodysplasia verruciformis (6, 7) , a rare inherited skin disease, these viruses can spread unchecked and have been implicated in the development of nonmelanoma skin cancer (NMSC), particularly in sun-exposed areas (8) .
The causal relationship between HPV infection and squamous cell carcinoma (SCC) of the genital tract is well established. HPV β-genotypes are suspected of playing a role in skin cancers, but this has been difficult to establish using epidemiologic approaches due to the ubiquitous prevalence of these viruses in the general population and their absence in some cancers (4, 9) .
Transgenic mouse models have been used to gain insight into the transforming activities of β-HPV. Expression of the complete early genome region (CER) of HPV8 in transgenic mice was found to be sufficient for the spontaneous development of NMSC (10) . In addition, our group has shown the intrinsic oncogenic potential of HPV8 E2 (11) and HPV8 E6 (12) using transgenic animals. Once more using transgenic technology, several mouse lines have been developed that express E6/E7 from other β-genotypes, such as HPV38 (13) and HPV20 (14) , but HPV8 has thus far been the only cutaneous HPV type found to induce skin cancer completely on its own in the absence of any additional co-carcinogenic treatment.
Signal transducer and activator of transcription 3 (Stat3) is a transcription factor that belongs to a family of cytoplasmic proteins that participate in normal cellular responses to cytokines and growth factors (15) . Activation of a wide variety of cell surface receptors leads to the tyrosine phosphorylation of Stat3 (pStat3), which then dimerizes and translocates to the nucleus, where it modulates the expression of target genes that are involved in various physiologic functions, including cell cycle regulation, apoptosis, and cell differentiation (16, 17) . Knocking Stat3 out of the germline results in embryonic lethality (18) , implying that Stat3 has global and critical effects on development. Keratinocyte-specific Stat3null mice show that Stat3 plays a pivotal role in skin remodeling because the hair cycle and wound-healing processes are found to be severely compromised in these mice (19) . Chan and colleagues (20) went on to show that these knockouts are completely resistant to the two-stage carcinogenesis regimen using 7,12-dimethylbenz(a)anthracene as the initiator and 12-O-tetradecanoylphorbol-13-acetate as the promoter, thus indicating that Stat3 is essential for the development of chemically induced skin tumors in mice. In addition, they found that Stat3-deficient keratinocytes were highly sensitive to UVB-induced apoptosis, whereas overexpression of Stat3 or expression of a Stat3C transgene protected keratinocytes from UVB-induced apoptosis (21) (22) (23) (24) . All in all, these findings clearly show that Stat3 plays a critical role in both twostage chemical-induced and physical UVB-mediated skin carcinogenesis.
In this study, we address the in vivo role of Stat3 in HPV8induced skin carcinogenesis using HPV8-CER transgenic mice crossed with keratinocyte-specific Stat3-disrupted mice, and report the remarkable observation that heterozygous mice, carrying only one Stat3 functional allele, respond poorly to proliferation induced by viral oncogenic proteins. The present study shows, for the first time, that the reduced expression of the Stat3 gene has a significant effect on skin tumor development in this mouse model of viral carcinogenesis, and provides a rationale for evaluating the potential use of Stat3 inhibitors in the prevention and treatment of tumors associated with β-HPV infection.
Materials and Methods

Generation of transgenic mice
K14-HPV8/FVB transgenic mice have been previously described (10) . K5Cre-Stat3 wt/LoxP mice were obtained by crossing K5Cre transgenic mice expressing Cre recombinase under the control of the keratinocyte-specific keratin 5 (K5) promoter (25, 26) with Stat3 LoxP/LoxP animals previously described (kindly provided by Dr. David Levy, New York University; ref. 27 ). Mice were housed in accordance with The Guide for the Care and Use of Laboratory Animals.
Genotyping of progeny
Genomic DNA was isolated from tail biopsies of 7-day-old mice using the QIAamp Tissue kit (Qiagen) or from 0.5% dispase II (Roche)-and trypsin (Sigma)-treated full-thickness skin. PCR analysis to detect Stat3 wild-type (wt), floxed, or null alleles was performed using primers designed to amplify the DNA sequence between exons 15 and 22 (Fig. 1A) . Briefly, DNA (∼0.3 μg) was incubated with two forward primers ("A": 5′-CAGAACCAGGCGGCTCGTGTGC-G-3′, specific for intron 21; "C": 5′-GAAGGCAGGTCTCTCTGGT-GCTTC-3′, specific for intron 15) and one reverse primer ("B": 5′-GCTGCCAACAGCCACTGCCCCAG-3′, specific for intron 21; [final] = 0.25 μmol/L) in a final volume of 25 μL using REDTaq ReadyMix PCR Reaction Mix (Sigma). PCRs were performed on a MJ PTC-200 thermal cycler (Bio-Rad) using the following protocol: 94°C for 2 minutes; 35 cycles of 94°C for 45 seconds, 58°C for 40 seconds, and 72°C for 1 minute; and a final extension period at 72°C for 7 minutes. PCR products were separated by 2% agarose-TAE gel electrophoresis, and ethidium bromide staining was used to detect the separated bands. Stat3 band sizes were expected to be ∼140 bp for the wt allele, ∼240 bp for the floxed allele, and ∼400 bp for the null allele. The PCR protocols used for the Cre and HPV8 transgenes were previously described (10, 25) .
Preparation of epidermal cell lysates and Western blot analysis
Mice were sacrificed by cervical dislocation. The dorsal skin of the mice was shaved and depilated; the skin was then excised and the epidermis was peeled away from the dermis following overnight treatment with 0.5% dispase II (Roche) and then homogenized in lysis buffer containing 100 mmol/L Tris-HCl (pH 6.8), 1.25% β-mercaptoethanol, 4% SDS, 1% bromphenol blue, 10% glycerol, 25 μL/mL Protease Inhibitor Cocktail (Sigma), and 1 μL/100 μL Phosphatase Inhibitor Cocktail 2 (Sigma). Supernatants were analyzed for protein concentration using the QuantiPro BCA Assay kit (Sigma). Three whole-cell lysates were pooled, fractionated on 8% to 12% SDS-PAGE, and transferred to polyvinylidene difluoride membranes (Millipore). The following primary antibodies were used: Stat3 and pStat3 (clones 124H6 and D3A7; 1:1,000 and 1:2,000; Cell Signaling Technology), vimentin (clone V9; 1:3,000; Sigma), pan-epithelial keratin (clone Ks 5+8.22/C 22; 1:300; Progen Biotechnik), and actin (clone C4; 1:3,000; Chemicon).
Histologic and immunohistochemical analysis of the skin
Sections (4 μm thick) were cut from formalin-fixed and paraffin-embedded skin, deparaffinized, and rehydrated using standard procedures. Serial sections were either stained with H&E or used for immunostaining using primary antibodies raised against the following proteins: K5 (clone AF138; 1:500; Covance), K10 (1:1,000; Covance), proliferating cell nuclear antigen (PCNA; 1:4,000; Santa Cruz Biotechnology), Stat3 (1:100; Cell Signaling Technology), and pStat3 (clone D3A7; 1:50; Cell Signaling Technology). Endogenous peroxidase activity was blocked by treatment with 3% hydrogen peroxide in 1× PBS for 10 minutes. Antigen unmasking was performed by microwaving the sections for 10 minutes in 10 mmol/L citrate buffer (pH 6.0) for K5, K10, Stat3, and PCNA antibodies, and for pStat3 in 1 mmol/L EDTA (pH 8.0) for 12 minutes. For K5, K10, Stat3, and PCNA antibodies, we used the biotinylated universal anti-rabbit/mouse secondary antibody followed by incubation with the streptavidin-horseradish peroxidase complex (Vector Laboratories). For revelation of pStat3, we used the DAKO EnVision Plus Detection System. Bound antibodies were visualized by 3,3′-diaminobenzidine, counterstained with Mayer's hematoxylin, and mounted with VectaMount permanent mounting medium (Vector Laboratories).
Evaluation of epidermal thickness, PCNA, and pStat3 staining
Paraffin sections were stained with H&E, and the epidermal thickness was measured by using Image-Pro Plus 6.0 software technology. For the quantification of PCNA-and pStat3-positive staining cells, 10 random areas were selected for each mouse. The number of cells showing positive labeling and the total number of cells counted (1,000) were recorded by using Image-Pro Plus 6.0 software technology. An average percentage was then calculated based on the total number of cells and the number of positive staining cells from each set of 10 fields counted. 
Quantitative real-time reverse transcription-PCR
For the determination of E6 and E7 gene expression levels, RNA was extracted from 0.5% dispase II-and trypsin-treated full-thickness skin using the NucleoSpin RNA Extraction kit (Macherey-Nagel) and treated with DNase I (Sigma). Total RNA (1 μg) was retrotranscribed using the ImProm-II Reverse Transcription System (Promega). SYBR Green I quantitative real-time reverse transcription-PCR (qRT-PCR) was performed, and the housekeeping gene β-actin was used to normalize the variation in cDNA levels. Each standard curve was constructed using values from serially diluted HPV8-negative mouse cDNA mixed with plasmid encoding E6/E7 of HPV8. wt mouse cDNA was amplified to verify the absence of genomic contaminations. SYBR Green I amplifications were performed as previously described (10) using the GeneAmp 7000 Sequence Detection System (Applied Biosystems).
Statistical analysis
All statistical tests were performed using GraphPad Prism version 5.00 for Windows. Two-way ANOVA, followed by Bonferroni post tests, was used to analyze whether the differences in mean epidermal thickness and PCNA proliferating indices were affected by the Stat3 genotype. One-way ANOVA followed by the Bonferroni post test was used to analyze the differences in the pStat3 immunohistochemical score between genotypes. Finally, the Fisher's exact test was used to compare tumor incidences between mouse genotypes.
Results and Discussion
Phenotypes of skin-specific Stat3 knockout mice expressing HPV8 early genes
Mice with epidermis-restricted Stat3 deletion (K5Cre-Stat3 wt/LoxP mice) were mated with animals in which HPV8 early gene expression was driven by the K14 promoter (K14-HPV8 mice). The resulting K5Cre-Stat3 wt/LoxP /K14-HPV8 mice were then backcrossed with parental K14-HPV8 mice for six generations to yield a pure FVB/N background and finally interbred to generate all the possible genotypes detailed in Table 1 .
Because K5 and K14 proteins are expressed in the same cell lineages (28) , including the basal keratinocytes of the interfollicular epidermis and the outer root sheath (i.e., the follicular keratinocytes), the Stat3 −/− :HPV8 mice have a constitutive overexpression of the HPV8 early genes in the same cells as those carrying the Cre-mediated Stat3 ablation. Genotyping of the Stat3 gene for both alleles was carried out by genomic PCR (Fig. 1A and B ), and the efficiency and specificity of the Cre-mediated Stat3 disruption were determined by Western blot analysis (Fig. 1C ). Stat3 protein levels were dramatically reduced in homozygous mice as a consequence of the Cremediated Stat3 gene disruption, whereas levels were reduced by ∼50% in heterozygous mice compared with the parental mice. As expected, the epidermal lysates contained the epithelial-specific marker pan-keratin, but not the fibroblastspecific marker vimentin, confirming their purity.
Soon after birth, both Stat3 −/− and Stat3 −/− :HPV8 mice started to fail ( Fig. 2A ). Within postnatal day 10 (PD10), they exhibited lethargy, retarded development, spontaneous wounds, and sparse hair development. By PD12 to PD15, they developed patches of rough skin with scales and crusts and invariably died prematurely. Most homozygous mice died between 20 and 30 days after birth irrespective of whether they possessed the HPV8 transgenes or not; a few survived longer, but for no more than 40 days. Previous reports have shown that the K5 gene is expressed not only in the epidermis but also in the esophagus and stomach (25, 29, 30) ; Stat3 disruption would therefore also occur in these tissues as a consequence of K5-driven Cre expression. Indeed, no food was found in the stomach of the dead mice, and the esophagus was smaller in mutant mice than in wt mice (data not shown), suggesting that death was primarily caused by a defect in food intake as a result of esophagus dysfunction. The fact that the Stat3 −/− mice have a high morbidity rate and short life span meant that it was not possible to investigate the tumorigenic effects of HPV8 early genes in these mice. In contrast, mice carrying a single functional Stat3 allele did not show any overt phenotype or gross modifications of the skin and lived a normal average life span. These phenotype results are similar to those reported by Sano and colleagues (19) , but in our mouse model, they appear earlier and with stronger severity. The Cre-LoxP system used by Sano and colleagues specifically removed the tyrosine residue essential for phosphorylation (Tyr 705 ) and the mitogen-activated protein kinase recognition site spanning exons 21 to 22 within the Stat3 gene, deleting full-length Stat3 but allowing the expression of truncated form with possible residual activity. In contrast, the gene disruption strategy used in our study, resulting in the total deletion of exons 16 to 21, completely abolished Stat3 expression, thus justifying the stronger phenotype observed in our mouse model.
Histologic analysis and measurement of the epidermal thickness of the skin obtained from healthy areas of the different genotypes (four mice for each genotype) at ∼1 month of age revealed marked differences between wt and Stat3-null mice. The epidermis in the null mice was so thin that it was not possible to measure it ( Fig. 2B and E) , and there was no increase in epidermal layer thickness as a consequence of viral oncoprotein expression. Severely distorted hair follicles Research.
on April 20, 2017. © 2010 American Association for Cancer cancerres.aacrjournals.org Downloaded from could be observed that formed cysts filled with lamellar and eosinophilic material in the upper dermis, particularly in the Stat3 −/− :HPV8 mice. This alteration of hair architecture has been previously reported and is related to the lack of Stat3 in the outer root sheath cells (19) . In contrast, both stratification of the squamous epithelia of the skin and hair follicle development were normal in heterozygous mice. The epidermis of nontransgenic Stat3 +/− mice was slightly thinner than that of Stat3 +/+ and was not significantly thicker in Stat3 +/− : HPV8. In contrast, the total thickness of the epidermis of Stat3 +/+ :HPV8 mice was approximately doubled compared with their nontransgenic wt counterparts and significantly thicker than that of Stat3 +/− :HPV8 mice. Proliferation was also evaluated by PCNA immunostaining. Consistent with the results observed by measuring epidermal thickness, PCNA staining was not detectable in the epidermis of Stat3-null mice, nor was it present in the Stat3 −/− :HPV8 transgenic mice (Fig. 2C ). The number of PCNA-positive cells was significantly greater in the epidermis of Stat3 +/+ :HPV8 compared with their nontransgenic counterparts, and no significant difference was found between Stat3 +/− :HPV8 mice and the nontransgenic Stat3 +/− mice (Fig. 2F) . Here, again, the number of PCNA-positive cells was significantly greater in Stat3 +/+ : HPV8 mice compared with Stat3 +/− :HPV8 mice.
Keratinocyte-specific ablation of Stat3 expression was confirmed by immunohistochemistry. As shown in Fig. 2D , strong positive immunostaining was observed in all layers of the epithelium in both Stat3 +/+ and Stat3 +/+ :HPV8 skin sections. According to the protein levels detected by Western blotting (Fig. 1C ), Stat3 expression was significantly reduced in heterozygous mice in comparison with wts, yet remained present in all layers of the epithelium. As expected, Stat3 staining was absent in the skin of Stat3 −/− mice in both interfollicular epidermis and follicular keratinocytes. Collectively, these findings indicate that, even in nonlesional skin of heterozygous mice, the reduction of Stat3 protein levels significantly affects the degree of hyperplasia induced by HPV8 oncoproteins.
Stat3 heterozygosity significantly decreases HPV8induced tumor formation
From our initial characterization of the different mouse genotypes, to our surprise, we noted that spontaneous skin lesions in a sample of Stat3 +/− :HPV8 mice did not occur during an observation period that spanned the first 3 months of life. On account of this finding, we monitored spontaneous tumor formation over a 52-week period in a larger cohort of Stat3 +/− :HPV8 mice (n = 23) and Stat3 +/+ :HPV8 mice (n = 81). All animals were followed for a minimum of 12 weeks. The Kaplan-Meier plot of the tumor-free state as a function of time showed statistically significant differences between the two groups ( Fig. 3) , with a disease-free survival greatly enhanced in the Stat3 heterozygous mice. The median age for tumor appearance was 10 weeks in Stat3 +/+ :HPV8 mice (P < 0.0001, log-rank test). Indeed, only 3 of the 23 Stat3 +/− : HPV8 mice (13%) displayed tumor formation within 12 weeks of life, whereas in the same period 44 of the 81 Stat3 +/+ : HPV8 mice had already developed one or more tumors (54.3%; Table 2 ). No influence of gender on tumor development was detected. The macroscopic appearance and the localization of the skin lesions in Stat3 +/+ :HPV8 were identical to the skin tumors previously described in HPV8-CER mice (10) . These lesions progressed continuously (15.8% of tumors progressed to malignancy) and never regressed. Interestingly, in Stat3 heterozygous mice, all the tumors were benign, as they did not exhibit any signs of ulceration, although they developed in the same location and with the same initial morphology as those in Stat3 +/+ :HPV8 mice. Indeed, they remained circumscribed and reduced in size for the entire observation period, whereas lesions in the Stat3 +/+ :HPV8 mice became more hyperkeratotic and spread diffusely. Overall, skin lesions in Stat3 +/− :HPV8 mice did not progress, neither did they show any signs of regression. Because three of the five Stat3 +/− :HPV8 mice that developed skin lesions were sacrificed for immunohistochemical analysis, sample numbers were too small to conclude with statistics that they would not have progressed to malignancy as occurred in the wt counterparts. It is worth noting, however, that the two Stat3 +/− :HPV8 mice that lived longer than the observation period (12 months) never developed any signs of malignant progression. Collectively, these observations show that the susceptibility to HPV8-induced skin tumor development is significantly reduced under conditions of Stat3 heterozygosity.
To verify that the results obtained were not related to different transgene expression levels between the wt and heterozygous mice, the levels of HPV8 E6 and HPV8 E7 mRNA in total RNA isolated from epidermal lysates of nonlesional skin in Stat3 +/+ :HPV8 and Stat3 +/− :HPV8 animals (three of each genotype) were measured in duplicate by qRT-PCR. Epidermal expression levels of the HPV8 E6 and HPV8 E7 mRNAs did not differ between mice of the same genotype or between mice of different genotype and were highest for E7 as previously reported. The mean range values (±SE) were 0.22 ± 0.01 versus 0.16 ± 0.06 for E6 transcripts in Stat3 +/+ :HPV8 versus Stat3 +/− :HPV8 mice, and 0.43 ± 0.12 versus 0.47 ± 0.24 for E7 transcripts in Stat3 +/+ :HPV8 versus Stat3 +/− :HPV8, respectively. As a further control, the HPV8 transgene copy number was determined by qRT-PCR in tumor-bearing mice from either Stat3 +/+ :HPV8 or Stat3 +/− : HPV8 and compared with tumor-free mice from both groups and Stat3 +/+ :HPV8 mice showing SCC progression. The proportion of hemizygous (30%) or homozygous (70%) animals for the HPV8 transgene was equally distributed, excluding the possibility that the results obtained were due to accumulation of HPV8 homozygous mice in a specific group during interbreeding (data not shown).
Assessment of Stat3 status, tumor growth, and proliferation
As stated above and shown in the representative example reported in Fig. 4A , lesions in 15.8% of Stat3 +/+ :HPV8 mice spontaneously progressed from papilloma to carcinoma over a time period of 8 to 24 weeks from their onset, at an average age of 17.3 weeks. Tumors arising in Stat3 +/+ :HPV8 mice were mostly ulcerated and invasive, features of malignancy. This progression was never observed in Stat3 +/− :HPV8 mice where lesions were limited in size and self-contained, thus indicative of benign papillomas, even at older ages (e.g., 20 weeks), as reported in the example of Fig. 4 (right column) . The histopathologic analysis confirmed they were all benign papillomas containing an endophytic component that grew toward the dermis (Fig. 4A, middle right) . They possessed concentrically keratinized structures, a common feature of β-HPVinduced hyperplasia. Even in older Stat3 +/− :HPV8 mice, these lesions never showed signs of early malignant transformation, such as hyperchromatic nuclei, loss of stratification, and mitotic figures in the upper cell layers; such features were commonly detected in the lesions obtained from the Stat3 +/+ :HPV8 mice of the same age (data not shown). Papillomas arising in Stat3 +/+ :HPV8 mice displayed the same histologic features described for Stat3 +/− :HPV8. In contrast, carcinomas arising in Stat3 +/+ :HPV8 mice showed loss of epithelium stratification, with markedly atypical cells, and infiltrative growth of tumor cells into the underlying connective tissue (Fig. 4A, middle column) . Collectively, these results show that a reduction in Stat3 protein levels strongly affects the progression of skin carcinogenesis.
Having established that Stat3 plays a crucial role in keratinocyte transformation induced by HPV8 early genes in vivo, we determined whether there had been any effect on the status of Stat3 phosphorylation. Following phosphorylation, Stat3 translocates to the nucleus, becomes transcriptionally active, and promotes the development of epidermal hyperplasia and/or malignant tumors in mice (22) . Immunohistochemical analysis revealed keratinocytespecific nuclear localization of the tyrosine-phosphorylated (activated) form of Stat3 (pStat3) in all the lesions analyzed from both Stat3 +/+ :HPV8 and Stat3 +/− :HPV8 mice (Fig. 4A , bottom row) in the basal and suprabasal layers. In nonlesional skin of both genotypes, pStat3 nuclear localization was restricted to just a few cells in the basal proliferating layer of the epidermis (data not shown). The number of pStat3-positive cells was significantly higher in the papillomas arising in both the Stat3 +/+ :HPV8 and Stat3 +/− : HPV8 mice compared with nonlesional epidermis from both genotypes, and moreover, the scores were similar in the papillomas (Fig. 4B ). In Stat3 +/+ :HPV8 mice, scores for pStat3 nuclear staining were higher for carcinomas than for papillomas. Upregulation of the Stat3 protein as well as its activation in the tumors that arose in both wt and heterozygous mice were also confirmed by immunoblotting ( Fig. 4C ). Thus, these results clearly indicate that Stat3 activation is associated with HPV8-induced hyperproliferation, and suggest that a requisite level of activated Stat3 must accumulate for a neoplasia to develop.
In addition, to analyze the proliferative status of the skin cells, nuclei were stained for the presence of PCNA (Fig. 5 , top row). Expression of the viral oncoproteins increased the number of PCNA-positive cells in the suprabasal layers of papillomas from both Stat3 +/+ :HPV8 and Stat3 +/− :HPV8 mice, although in heterozygous mice the staining was more disorganized with a higher number of positive cells in the inner suprabasal layers. As expected, PCNA expression in carcinomas from Stat3 +/+ :HPV8 mice extended all the way through the dysplastic epidermis.
To assess whether the differences in HPV8-induced tumor progression in Stat3 +/+ versus Stat3 +/− were associated with the degree of tumor cell differentiation, we evaluated the expression of a marker of suprabasal differentiated keratinocytes (K10) and of undifferentiated basal (K5) compartments of the epidermis. In control epidermis, K10 is expressed by postmitotic keratinocytes in the suprabasal layers during normal differentiation (data not shown). As shown in Fig. 5 (middle row) , the hyperplasia of suprabasal keratinocytes induced by HPV8 oncoproteins in papillomas and carcinomas from Stat3 +/+ :HPV8 mice was paralleled by a strong reduction of K10 expression in the inner suprabasal layers; expression was shifted outwards, sporadically observed in the flattened cells positioned just beneath the malformed corny layer. A similar pattern was observed in the papillomas from heterozygous mice, although clusters of K10-positive cells were still present in the more differentiated areas of the concentrically keratinized structures. The increased proliferation and hyperplasia of suprabasal keratinocytes induced by viral oncoprotein expression was accompanied by the accumulation of less differentiated suprabasal cells. This was indicated by the persistent expression of the basal marker K5 in the suprabasal layers and its retention throughout the hyperplastic epidermis (Fig. 5, bottom row) . It is also worth mentioning that K5-positive invading keratinocytes were present in the dermal compartment of Stat3 +/+ :HPV8 papillomas, confirming that these lesions are malignant, but never in Stat3 +/− : HPV8 papillomas.
The physiologic importance of Stat3 in the maintenance of skin integrity as well as the pathogenesis of skin diseases has been described in many experimental settings, including in vitro cell culture systems (19, 21, 31) and skin-specific Stat3-deficient mice obtained by conditional gene targeting (19) . In the current study, by using a different Cre-LoxP strategy to that used by Sano and colleagues (19) , we have confirmed the fundamental role of Stat3 in the maintenance of hair growth and epidermal homeostasis. Indeed, histology of the skin from Stat3 −/− mice revealed severe epidermal loss and alteration of hair architecture.
To comprehend further the biological functions of Stat3, we addressed the question of whether more subtle changes in Stat3 expression could also influence tumor development in our experimental setting. Stat3 +/− mice appeared identical to their Stat3 +/+ littermates: They had no apparent abnormalities and lived a normal average life span. However, comparing tumor yields in Stat3 +/+ :HPV8 versus Stat3 +/− : HPV8 mice revealed surprisingly highly significant effects of Stat3 heterozygosity on skin tumor susceptibility triggered by HPV8 early genes. Despite the rather modest effect on Stat3 expression, the effect on tumor development was considerable: Significantly fewer tumors were produced in Stat3 +/− :HPV8 mice compared with Stat3 +/+ :HPV8 mice, a finding that provides genetic proof of the notion that even a relatively modest reduction in Stat3 expression can indeed affect tumor development in a rather profound manner. Moreover, all the tumors in the Stat3 heterozygous mice showed signs of being benign and never progressed to a more malignant phenotype. The rate and extent of keratinocyte proliferation, the delay in keratinocyte differentiation, and the level of pStat3 positively stained nuclei were similar between papillomas arising in Stat3 +/+ :HPV8 and Stat3 +/− :HPV8 mice. These findings indicate that a certain amount of activated Stat3 is necessary to achieve uncontrolled proliferation, and therefore, only cells that display the appropriate levels of Stat3 will be capable of proliferating in response to the viral oncoproteins. Our findings support the emerging concept that differences in tissue expression levels of proteins involved in cell cycle control, resulting from either overexpression or reductions, can affect tumor susceptibility (32) . Furthermore, a surprising number of complicated clinical manifestations associated with genetic syndromes are due to mutations in genes encoding transcription factors (33) . The mechanism through which transcription factor defects cause disease is often heterozygosity, indicating that half-normal levels of many transcription factors are simply not enough to provide normal function (34) .
A causal link between Stat3 ablation and reduction in tumor yield was also shown by Bollrath and colleagues (35) in their Stat3 ΔIEC , mice where Stat3 was selectively knocked out in all the epithelial cell lineages of the intestine. The Stat3 ΔIEC mice were generated by a Cre-LoxP strategy expressing Cre recombinase under the control of the intestine-specific villin gene promoter. Exposure of these Stat3 ΔIEC mice to the colitis-associated cancer challenge revealed that they were almost completely protected from the development of tubular adenomas induced by the colonotropic mutagen azoxymethane. Consistent with our findings, the few polypoid lesions protruding into the lumen that developed in a small proportion of Stat3 ΔIEC mice were markedly reduced in size.
Collectively, these studies provide for the first time evidence of a critical role of Stat3 in the experimental mouse model of HPV8-induced epithelial carcinogenesis and suggest that targeting Stat3 in keratinocytes may be a viable strategy for the prevention and treatment of HPV-induced skin cancer.
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